Identification of hepatic NPC1L1 as an NAFLD risk factor evidenced by ezetimibe‐mediated steatosis prevention and recovery

Yu Toyoda(University of Tokyo Hospital), Hiroshi Suzuki(University of Tokyo Hospital)
FASEB BioAdvances
February 13, 2019
Cited by 28


Related Papers

No related papers found

Powered by citation graph analysis